Literature DB >> 2062186

Lectin binding to normal mucosa, leukoplakia and squamous cell carcinoma of the oral cavity.

D P May1, P Sloan.   

Abstract

A panel of fifteen biotinylated lectins was used to study the saccharides associated with the epithelial component of normal and leukoplakic mucosa and squamous cell carcinoma, from a variety of locations in the oral cavity. Lectin binding heterogeneity was found between various sites of normal mucosa. The binding to leukoplakic epithelium closely resembled normal, with similar site heterogeneity. However, the features of cell-capping and cellular expression of the blood group A antigen, as observed in normal and most leukoplakic epithelia, were not observed in squamous cell carcinoma. These results show that neoplasia in oral squamous epithelium is associated with alterations in terminal N-acetyl-D-galactosamine, N-acetyl-D-glucosamine, D-mannose, L-fucose, D-glucosamine and D-galactosamine residues present in the outer parts of both O-linked and N-linked glycoconjugates, along with high levels of terminal sialation of certain residues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2062186

Source DB:  PubMed          Journal:  Med Lab Sci        ISSN: 0308-3616


  3 in total

1.  Expression of lectin-specific cellular glycoconjugates during oral carcinogenesis.

Authors:  S Kannan; P Balaram; G J Chandran; M R Pillai; B Mathew; M K Nair
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

2.  Enhancement of glycosylation of cellular glycoconjugates in the squamous carcinoma cell line MDA886Ln by beta-all-trans retinoic acid.

Authors:  P G Sacks; B Amos; R Lotan
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

3.  Molecular imaging of oral premalignant and malignant lesions using fluorescently labeled lectins.

Authors:  John Baeten; Amritha Suresh; Alexander Johnson; Ketan Patel; Moni Kuriakose; Anita Flynn; Deepak Kademani
Journal:  Transl Oncol       Date:  2014-03-04       Impact factor: 4.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.